A number of US hospitals are pressing ahead with plans to launch their own generics company, Civica Rx, with the appointment of Martin VanTrieste as chief execu 11 September 2018
Following reports in Israeli press last week that struggling generics giant Teva Pharmaceutical Industries (NYSE.TEVA) is gearing up to slash its global workfor 27 November 2017
Just 14 months after taking the reins at Perrigo, John Hendrickson is to retire from his position as chief executive at the Ireland-incorporated generics drugma 6 June 2017
Investors were clearly impressed by the appointment of Paul Bisaro as the chief executive of USA-based generics company Impax Laboratories as the firm’s share v 28 March 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.